Tempus AITEM +6.85%35 ROE % is -110.97% as of Mar. 2026. GuruFocus rates TEM with a GF Score™ of 35/100. The stock has 3 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Tempus AI ranks worse than 92.04% on this metric.
ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Tempus AI's annualized net income for the quarter that ended in Mar. 2026 was $-504 Mil. Tempus AI's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $454 Mil. Therefore, Tempus AI's annualized ROE % for the quarter that ended in Mar. 2026 was -110.97%.
The historical rank and industry rank for Tempus AI's ROE % or its related term are showing as below:
TEM'
s ROE % Range Over the Past 10 Years
Min: -89.48 Med: -89.48 Max: -73.83
Current: -73.83
During the past 7 years, Tempus AI's highest ROE % was -73.83%. The lowest was -89.48%. And the median was -89.48%.
TEM's ROE % is ranked worse than 92.04% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 5.72
vs TEM: -73.83
Tempus AI (NAS:TEM) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Tempus AI ROE % Related Terms
Tempus AI ROE % Historical Data
* Premium members only.
The historical data trend for Tempus AI's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Tempus AI's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tempus AI ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tempus AI's ROE % distribution charts can be found below:
* The bar in red indicates where Tempus AI's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Tempus AI (TEM) has a ROE % of -110.97% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tempus AI and its competitors. According to the industry distribution chart, Tempus AI ranks #578 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 92%.
Is Tempus AI's ROE % too high?
Tempus AI's current ROE % is -110.97%. Based on the distribution chart, Tempus AI ranks #578 out of 628 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Tempus AI has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Tempus AI's ROE % compare to HQY and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Tempus AI ranks #578 out of 628 companies for ROE %. This places Tempus AI in the lower half of its industry. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tempus AI and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tempus AI's current ROE % is -110.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tempus AI stock overvalued right now?
Tempus AI (TEM) has a current ROE % of -110.97%. The current ROE % is -110.97%. Tempus AI's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Tempus AI (TEM), the current ROE % is -110.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
35GF Score
Get the complete analysis for TEM
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TEM has been successfully added to your 
